Clinical Trial Update: NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NAD+ augmentation for ischemia-reperfusion injury with associated myocardial and kidney injuries is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• Kidney Injury
• Myocardial Injury

Drugs mentioned

• NAD+ augmentation

Snippet

Sponsor: Kaiser Permanente | Conditions: Ischemia Reperfusion Injury, Myocardial Injury | Phase 2 | Status: RECRUITING